Necrosis‐like death with plasma membrane damage against cervical cancer cells by photodynamic therapy

In order to elucidate the antitumor effect of photodynamic therapy (PDT) using the photosensitizing agent hematoporphyrin derivative (Photogem) and a diode laser, we evaluated the cell death of uterine cancer cell lines (CaSki, HT3, HeLa, and SKOV-3) and mice transplanted with TC-1 lung cancer cells. Morphological changes, MTT assay, flow cytometry, cytotoxicity, and tumor growth-inhibition study were evaluated at various time intervals after PDT. The results showed that the survival rates of each cell line decreased with time and dose–response after performing PDT. Also, PDT-induced damage of cancer cells was almost entirely confined to necrosis of the tumor cells in the early time courses. The irradiation of CaSki cells in the presence of Photogem induced plasma membrane disruption and cell shrinkage, indicating the plasma membrane as the main target for Photogem. In the experiment in vivo, the time courses of Photogem with irradiation showed significantly longer survival and a significantly smaller tumor size compared to those in the untreated control groups, and resorption of the tumor after PDT treatment was observed. Collectively, our results indicated that Photogem possesses tumor-specific affinity, and necrosis-like death with plasma membrane damage was postulated to be the principal mechanism of the antitumor effect of PDT using Photogem.

[1]  S. Hahn,et al.  Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. , 1999, Cancer research.

[2]  T. Ageeva,et al.  Meeting Reports and Abstracts: Symposium on Applications of Porphyrins in Medicine and the Fourth School for Young Scientists on the Chemistry of Porphyrins and Related Compounds Ivanovo 2000 , 2000 .

[3]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[4]  M. Obochi,et al.  New Applications in Photodynamic Therapy Introduction , 1996, Photochemistry and photobiology.

[5]  L. Formigli,et al.  Aponecrosis: Morphological and biochemical exploration of a syncretic process of cell death sharing apoptosis and necrosis , 2000, Journal of cellular physiology.

[6]  L. Penning,et al.  A role for the transient increase of cytoplasmic free calcium in cell rescue after photodynamic treatment. , 1992, Biochimica et biophysica acta.

[7]  P. Vandenabeele,et al.  Apoptotic and necrotic cell death induced by death domain receptors , 2001, Cellular and Molecular Life Sciences CMLS.

[8]  D. Kessel,et al.  Localization and Efficacy Analysis of the Phototherapeutic Lutetium Texaphyrin (PCI‐0123) in the Murine EMT6 Sarcoma Model , 1997, Photochemistry and photobiology.

[9]  T. Dougherty.  An update on photodynamic therapy applications. , 2002, Journal of clinical laser medicine & surgery.

[10]  M. Dellinger.  Apoptosis or Necrosis Following Photofrin® Photosensitization: Influence of the Incubation Protocol , 1996, Photochemistry and photobiology.

[11]  S. Yang,et al.  Apoptotic signalling cascade in photosensitized human epidermal carcinoma A431 cells: involvement of singlet oxygen, c-Jun N-terminal kinase, caspase-3 and p21-activated kinase 2. , 2000, The Biochemical journal.

[12]  Hiroshi Nakamura,et al.  Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines , 2001, International Journal of Gynecologic Cancer.

[13]  A M Prokhorov,et al.  [Clinical fluorescent diagnosis of tumors using photosensitizer photogem]. , 1995, Khirurgiia.

[14]  B. Henderson,et al.  Release of prostaglandin E2 from cells by photodynamic treatment in vitro. , 1989, Cancer research.

[15]  P. Morlière,et al.  The role of the low density lipoprotein receptor pathway in the delivery of lipophilic photosensitizers in the photodynamic therapy of tumours. , 1991, Journal of photochemistry and photobiology. B, Biology.

[16]  N. Brown,et al.  Differential cell death response to photodynamic therapy is dependent on dose and cell type , 2001, British Journal of Cancer.

[17]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.

[18]  Chih-Ching Wu,et al.  Subcellular localization of Photofrin® determines the death phenotype of human epidermoid carcinoma A431 cells triggered by photodynamic therapy: When plasma membranes are the main targets , 2003, Journal of cellular physiology.

[19]  M. Melamed,et al.  Analysis of apoptosis by laser scanning cytometry. , 1999, Cytometry.

[20]  T. Dougherty,et al.  HOW DOES PHOTODYNAMIC THERAPY WORK? , 1992, Photochemistry and photobiology.

[21]  G. Miotto,et al.  Photosensitization with zinc (II) phthalocyanine as a switch in the decision between apoptosis and necrosis. , 2001, Cancer research.

[22]  A. Girotti,et al.  Photooxidation of cell membranes in the presence of hematoporphyrin derivative: reactivity of phospholipid and cholesterol hydroperoxides with glutathione peroxidase. , 1988, Biochimica et biophysica acta.

[23]  A. Moor,et al.  Signaling pathways in cell death and survival after photodynamic therapy. , 2000, Journal of photochemistry and photobiology. B, Biology.

[24]  N. Oleinick,et al.  The photobiology of photodynamic therapy: cellular targets and mechanisms. , 1998, Radiation research.

[25]  Sharon Thomsen,et al.  PHOTODYNAMIC THERAPY WITH PHOTOFRIN II INDUCES PROGRAMMED CELL DEATH IN CARCINOMA CELL LINES , 1994, Photochemistry and photobiology.